Login to Your Account



Genentech Says Avastin Data in Colon Cancer Moved Up

By Donna Young


Monday, May 19, 2008
There were no surprises in abstract information released late Thursday night about Avastin (bevacizumab) in a Phase III trial in early stage colon cancer. However, Genentech Inc. revealed that final safety and efficacy results from the trial would be available a year earlier than expected, 2009 rather than 2010. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription